ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2025
SMAGS-LASSO: A Novel Feature Selection Method for Sensitivity Maximization in Early Cancer Detection.
Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundSensitivity and specificity are foundational metrics for cancer detection tools. However, most machine learning algorithms prioritize overall accuracy during optimization, which fails to align with clinical priorities of early detection. We aim to develop a feature selection machine learning algorithm while maximizing sensitivity at a given specificity.
methodsWe developed SMAGS-LASSO, a machine learning algorithm that combines our developed Sensitivity Maximization at a Given Specificity (SMAGS) framework with L1 regularization for feature selection. This approach simultaneously optimizes sensitivity at user-defined specificity thresholds while performing feature selection. SMAGS-LASSO utilizes a custom loss function with L1 regularization and multiple parallel optimization techniques. We used train-test splits and cross-validation, comparing against LASSO and random forest using sensitivity and AUC metrics. We evaluated our method on synthetic datasets and real-world protein colorectal cancer biomarker data.
resultsIn synthetic datasets designed to contain strong signals for both sensitivity and specificity, SMAGS-LASSO significantly outperformed standard LASSO, achieving sensitivity of 1.00 (95% confidence interval, 0.98-1.00) compared with 0.19 (95% confidence interval, 0.13-0.23) for LASSO at 99.9% specificity. In colorectal cancer data, SMAGS-LASSO demonstrated 21.8% improvement over LASSO (P value = 2.24E-04) and 38.5% over random forest (P value = 4.62E-08) at 98.5% specificity while selecting the same number of biomarkers.
conclusionsSMAGS-LASSO enables the development of minimal biomarker panels that maintain high sensitivity at predefined specificity thresholds, offering superior performance for early cancer detection. IMPACT: This method provides a promising approach for early cancer detection and other medical diagnostics requiring sensitivity-specificity optimization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.